These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Thromboelastographic profiles as a tool for thrombotic risk in digestive tract cancer. Papa ML; Capasso F; Pudore L; Torre S; Mango S; Russo V; Delrio P; Palaia R; Ruffolo F; d'Eufemia MD; De Lucia D; Napolitano M; Di Micco P; Parisi V Exp Oncol; 2007 Jun; 29(2):111-5. PubMed ID: 17704742 [TBL] [Abstract][Full Text] [Related]
4. AB0 blood group and risk of venous or arterial thrombosis in carriers of factor V Leiden or prothrombin G20210A polymorphisms. Miñano A; Ordóñez A; España F; González-Porras JR; Lecumberri R; Fontcuberta J; Llamas P; Marín F; Estellés A; Alberca I; Vicente V; Corral J Haematologica; 2008 May; 93(5):729-34. PubMed ID: 18387978 [TBL] [Abstract][Full Text] [Related]
5. Are patients with thrombophilia and previous venous thromboembolism at higher risk to arterial thrombosis? Linnemann B; Schindewolf M; Zgouras D; Erbe M; Jarosch-Preusche M; Lindhoff-Last E Thromb Res; 2008; 121(6):743-50. PubMed ID: 17804043 [TBL] [Abstract][Full Text] [Related]
6. Fibrinolysis or hypercoagulation during radical prostatectomy? An evaluation of thrombelastographic parameters and standard laboratory tests. Ziegler S; Ortu A; Reale C; Proietti R; Mondello E; Tufano R; di Benedetto P; Fanelli G Eur J Anaesthesiol; 2008 Jul; 25(7):538-43. PubMed ID: 18339213 [TBL] [Abstract][Full Text] [Related]
7. Thrombin generation in first-degree relatives of patients with venous thromboembolism who have factor V Leiden. A pilot study. Couturaud F; Duchemin J; Leroyer C; Delahousse B; Abgrall JF; Mottier D; Thromb Haemost; 2008 Jan; 99(1):223-8. PubMed ID: 18217158 [TBL] [Abstract][Full Text] [Related]
8. Laboratory markers in the diagnosis of venous thromboembolism. Caprini JA; Glase CJ; Anderson CB; Hathaway K Circulation; 2004 Mar; 109(12 Suppl 1):I4-8. PubMed ID: 15051662 [TBL] [Abstract][Full Text] [Related]
9. Interrelation of hyperhomocysteinemia and inherited risk factors for venous thromboembolism. Results from the E.D.I.TH. study: a hospital-based case-control study. Oger E; Lacut K; Le Gal G; Couturaud F; Abalain JH; Mercier B; Mottier D; Thromb Res; 2007; 120(2):207-14. PubMed ID: 17126889 [TBL] [Abstract][Full Text] [Related]
10. Noncitrated whole blood is optimal for evaluation of postinjury coagulopathy with point-of-care rapid thrombelastography. Kashuk JL; Moore EE; Le T; Lawrence J; Pezold M; Johnson JL; Cothren CC; Biffl WL; Barnett C; Sabel A J Surg Res; 2009 Sep; 156(1):133-8. PubMed ID: 19577246 [TBL] [Abstract][Full Text] [Related]
11. Thromboelastography in patients with cerebral venous thrombosis. Koopman K; Uyttenboogaart M; Hendriks HG; Luijckx GJ; Cramwinckel IR; Vroomen PC; De Keyser J; van der Meer J Thromb Res; 2009 Jun; 124(2):185-8. PubMed ID: 19187954 [TBL] [Abstract][Full Text] [Related]
12. A direct thrombin inhibitor studied by dynamic whole blood clot formation. Haemostatic response to ex-vivo addition of recombinant factor VIIa or activated prothrombin complex concentrate. Sørensen B; Ingerslev J Thromb Haemost; 2006 Oct; 96(4):446-53. PubMed ID: 17003921 [TBL] [Abstract][Full Text] [Related]
13. Tailoring haemostatic treatment to patient requirements - an update on monitoring haemostatic response using thrombelastography. Sørensen B; Ingerslev J Haemophilia; 2005 Nov; 11 Suppl 1():1-6. PubMed ID: 16219042 [TBL] [Abstract][Full Text] [Related]
14. Thrombophilia and venous thromboembolism: implications for testing. Cohn DM; Roshani S; Middeldorp S Semin Thromb Hemost; 2007 Sep; 33(6):573-81. PubMed ID: 17768689 [TBL] [Abstract][Full Text] [Related]
15. Endogenous thrombin potential for predicting risk of venous thromboembolism in carriers of factor V Leiden. Lincz LF; Lonergan A; Scorgie FE; Rowlings P; Gibson R; Lawrie A; Seldon M Pathophysiol Haemost Thromb; 2006; 35(6):435-9. PubMed ID: 17565236 [TBL] [Abstract][Full Text] [Related]
16. Venous thromboembolism in carriers of the Factor V Leiden mutation and in patients without known thrombophilic risk factor; prediction of recurrence and APC-PCI complex concentration and/or soluble thrombomodulin antigen and activity. Strandberg K; Svensson PJ; Ohlin AK Thromb Res; 2007; 121(2):145-51. PubMed ID: 17499343 [TBL] [Abstract][Full Text] [Related]
17. [Venous thromboembolic disease: which coagulation screening, for whom, when?]. Wautrecht JC Rev Med Brux; 2005 Sep; 26(4):S315-9. PubMed ID: 16240880 [TBL] [Abstract][Full Text] [Related]
18. Should patients with venous thromboembolism be screened for thrombophilia? Dalen JE Am J Med; 2008 Jun; 121(6):458-63. PubMed ID: 18501222 [TBL] [Abstract][Full Text] [Related]
19. Thrombophilia and cancer. Horowitz N; Brenner B Pathophysiol Haemost Thromb; 2008; 36(3-4):131-6. PubMed ID: 19176986 [TBL] [Abstract][Full Text] [Related]
20. Haemostatic changes in the puerperium '6 weeks postpartum' (HIP Study) - implication for maternal thromboembolism. Saha P; Stott D; Atalla R BJOG; 2009 Nov; 116(12):1602-12. PubMed ID: 19681851 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]